CAV1 and Alzheimer disease: Further Mfsd2a reduction promotes caveolae-mediated transcytosis [99] and increased levels of caveolin-1 have been observed in the frontal cortex and hippocampus of post-mortem AD compared to aged-matched control subjects [100].